-
EP3177298
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3177298
| EP3177298 - METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITORS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 29.03.2019 Database last updated on 18.11.2024 | |
| Former | Request for examination was made Status updated on 12.05.2017 | ||
| Former | The international publication has been made Status updated on 04.03.2017 | Most recent event Tooltip | 29.03.2019 | Application deemed to be withdrawn | published on 01.05.2019 [2019/18] | Applicant(s) | For all designated states The Johns Hopkins University 3400 North Charles Street Baltimore, MD 21218 / US | [2017/24] | Inventor(s) | 01 /
SLUSHER, Barbara 7424 Longfield Drive Kingsville, Maryland 21087 / US | 02 /
LI, Xuhang 6529 Ballymore Lane Clarksville, Maryland 21029 / US | 03 /
RAIS, Rana 12905 Vistaview Dr. West Friendship, MD 21794 / US | [2017/24] | Representative(s) | Murgitroyd & Company 165-169 Scotland Street Glasgow G5 8PL / GB | [N/P] |
| Former [2017/24] | Fyfe, Fiona Allison Watson Murgitroyd & Company Scotland House 165-169 Scotland Street Glasgow G5 8PL / GB | Application number, filing date | 15829737.4 | 06.08.2015 | [2017/24] | WO2015US44025 | Priority number, date | US201462033948P | 06.08.2014 Original published format: US 201462033948 P | [2017/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2016022809 | Date: | 11.02.2016 | Language: | EN | [2016/06] | Type: | A2 Application without search report | No.: | EP3177298 | Date: | 14.06.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.02.2016 takes the place of the publication of the European patent application. | [2017/24] | Search report(s) | International search report - published on: | KR | 11.02.2016 | (Supplementary) European search report - dispatched on: | EP | 12.03.2018 | Classification | IPC: | A61K31/66, A61K31/192, A61K31/194, A61P1/00, A61P29/00, A61K9/00, A61K9/02, A61K31/662 | [2018/15] | CPC: |
A61K31/662 (EP,US);
A61K31/194 (EP,US);
A61K9/0031 (US);
A61K9/0053 (US);
A61K9/02 (US);
A61P1/00 (EP);
A61P29/00 (EP)
(-)
|
| Former IPC [2017/24] | A61K31/66, A61K31/192, A61K31/194, A61P1/00, A61P29/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/24] | Title | German: | VERFAHREN ZUR BEHANDLUNG VON ENTZÜNDLICHER DARMERKRANKUNG MIT INHIBITOREN DES PROSTATASPEZIFISCHEN MEMBRANANTIGENS (PSMA) | [2017/24] | English: | METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITORS | [2017/24] | French: | PROCÉDÉS DE TRAITEMENT DE LA MALADIE INFLAMMATOIRE DE L'INTESTIN À L'AIDE D'INHIBITEURS DE PSMA -ANTIGÈNE DE MEMBRANE SPÉCIFIQUE DE LA PROSTATE- | [2017/24] | Entry into regional phase | 03.03.2017 | National basic fee paid | 03.03.2017 | Search fee paid | 03.03.2017 | Designation fee(s) paid | 03.03.2017 | Examination fee paid | Examination procedure | 03.03.2017 | Examination requested [2017/24] | 03.03.2017 | Date on which the examining division has become responsible | 21.09.2017 | Amendment by applicant (claims and/or description) | 09.10.2018 | Application deemed to be withdrawn, date of legal effect [2019/18] | 27.11.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2019/18] | Fees paid | Renewal fee | 28.08.2017 | Renewal fee patent year 03 | 27.08.2018 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]US2007041934 (WILLIAM BERNELL [US], et al) [X] 1-4 * paragraphs [0020] , [ 267] , [ 271] - [0273]; claim 5 *; | [X]WO2009070302 (UNIV JOHNS HOPKINS [US], et al) [X] 1 * page 25, lines 17-18; claim 1 *; | [A] - K. M. WOZNIAK ET AL, "The Orally Active Glutamate Carboxypeptidase II Inhibitor E2072 Exhibits Sustained Nerve Exposure and Attenuates Peripheral Neuropathy", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, (20121201), vol. 343, no. 3, doi:10.1124/jpet.112.197665, pages 746 - 754, XP055454905 [A] 1,5-7 * abstract * DOI: http://dx.doi.org/10.1124/jpet.112.197665 |